01 · ABSTRACT
Abstract
Radiopharmaceutical therapy directly targets radioactive drugs to cancer cells. Incorporating radiopharmaceutical therapy requires quantitative assessment of the radiation dose delivered to the cancer cells and surrounding normal tissue(s). This paper discusses the necessity of tumor and normal tissue dosimetry processes in radiopharmaceutical therapy and strategies to align this therapy within a patient’s care plan. We discuss a process to manage radiopharmaceutical therapy within institutions to ensure dose metrics can be incorporated into the care plan for review by participants in patient care.
02 · PUBLICATION RECORD
Article details
JournalMedical Research Archives
IssueVol 12 No 4 (2024): April issue, Vol.12, Issue 4
SectionCase Reports
Published26 April 2024
DOI10.18103/mra.v12i4.5218
ISSN2375-1924
03 · RIGHTS & REUSE
Rights & reuse
This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.
